Rapid and dramatic radiographic and clinical ... [J Thorac Oncol. 2010] - PubMed

Save items

loading

Related citations in PubMed

Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. [J Thorac Oncol. 2011]
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Ou SH, Kwak EL, Siwak-Tapp C, Dy J, Bergethon K, Clark JW, Camidge DR, Solomon BJ, Maki RG, Bang YJ, et al. J Thorac Oncol. 2011 May; 6(5):942-6.
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. [N Engl J Med. 2010]
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, Ou SH, Dezube BJ, Jänne PA, Costa DB, et al. N Engl J Med. 2010 Oct 28; 363(18):1693-703.
Review Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases. [Curr Opin Investig Drugs. 2010]
Review Crizotinib, a small-molecule dual inhibitor of the c-Met and ALK receptor tyrosine kinases.
Rodig SJ, Shapiro GI. Curr Opin Investig Drugs. 2010 Dec; 11(12):1477-90.
ALK, lung cancer, and personalized therapy: portent of the future? [J Natl Cancer Inst. 2010]
ALK, lung cancer, and personalized therapy: portent of the future?
Garber K. J Natl Cancer Inst. 2010 May 19; 102(10):672-5. Epub 2010 May 11.
Review Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer. [Expert Rev Anticancer Ther. 2011]
Review Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.
Tiseo M, Gelsomino F, Bartolotti M, Bordi P, Bersanelli M, Rossi G, Ardizzoni A. Expert Rev Anticancer Ther. 2011 Nov; 11(11):1677-87.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond. [Drug Des Devel Ther. 2011]
Review Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged non-small cell lung cancer and beyond.
Ou SH. Drug Des Devel Ther. 2011; 5:471-85. Epub 2011 Nov 23.
Wnt signaling and colon carcinogenesis: beyond APC. [J Carcinog. 2011]
Wnt signaling and colon carcinogenesis: beyond APC.
Najdi R, Holcombe RF, Waterman ML. J Carcinog. 2011 Mar 17; 10:5. Epub 2011 Mar 17.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizo...
Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.
J Thorac Oncol. 2010 Dec ;5(12):2044-6.

PubMed
Medial and lateral pin versus lateral-entry pin fixation for Type 3 supracondyla...
Medial and lateral pin versus lateral-entry pin fixation for Type 3 supracondylar fractures in children: a prospective, surgeon-randomized study.
J Pediatr Orthop. 2010 Dec ;30(8):799-806.

PubMed
A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder.
A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder.
Int Clin Psychopharmacol. 1990 Jan ;5(1):17-30.

PubMed
Purification and characterization of glutathione transferases with an activity t...
Purification and characterization of glutathione transferases with an activity toward nitroglycerin from human aorta and heart. Multiplicity of the human class Mu forms.
J Biol Chem. 1990 May 5 ;265(13):7150-7.

PubMed
Genomic organization of the human amyloid beta-protein precursor gene.
Genomic organization of the human amyloid beta-protein precursor gene.
Gene. 1990 Mar 15 ;87(2):257-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Rapid and dramatic radiographic and clinical response to an ALK inhibitor (crizotinib, PF02341066) in an ALK translocation-positive patient with non-small cell lung cancer.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information